Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification

Rapid antigen tests for influenza, here referred to as rapid influenza diagnostic tests (RIDTs), have been widely used for the diagnosis of influenza since their introduction in the 1990s due to their ease of use, rapid results, and suitability for point of care (POC) testing. However, issues related to the diagnostic sensitivity of these assays have been known for decades, and these issues gained greater attention following reports of their poor performance during the 2009 influenza A(H1N1) pandemic. ABSTRACT Rapid antigen tests for influenza, here referred to as rapid influenza diagnostic tests (RIDTs), have been widely used for the diagnosis of influenza since their introduction in the 1990s due to their ease of use, rapid results, and suitability for point of care (POC) testing. However, issues related to the diagnostic sensitivity of these assays have been known for decades, and these issues gained greater attention following reports of their poor performance during the 2009 influenza A(H1N1) pandemic. In turn, significant concerns arose about the consequences of false-negative results, which could pose significant risks to both individual patient care and to public health efforts. In response to these concerns, the FDA convened an advisory panel in June 2013 to discuss options to improve the regulation of the performance of RIDTs. A proposed order was published on 22 May 2014, and the final order published on 12 January 2017, reclassifying RIDTs from class I to class II medical devices, with additional requirements to comply with four new special controls. This reclassification is a landmark achievement in the regulation of diagnostic devices for infectious diseases and has important consequences for the future of diagnostic influenza testing with commercial tests, warranting the prompt attention of clinical laboratories, health care systems, and health care providers.

[1]  D. Peaper,et al.  Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients , 2016, Journal of Clinical Microbiology.

[2]  Matthew J. Binnicker,et al.  Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay , 2015, Journal of Clinical Microbiology.

[3]  D. Dwyer,et al.  Detection of influenza A and B with the Alere™ i Influenza A & B: a novel isothermal nucleic acid amplification assay , 2015, Influenza and other respiratory viruses.

[4]  F. Hassan,et al.  Comparison of the BD Veritor System for Flu A+B with the Alere BinaxNOW Influenza A&B Card for Detection of Influenza A and B Viruses in Respiratory Specimens from Pediatric Patients , 2014, Journal of Clinical Microbiology.

[5]  A. Kelso,et al.  A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  A. Dugas,et al.  Evaluation of 11 commercially available rapid influenza diagnostic tests--United States, 2011-2012. , 2013, MMWR. Morbidity and mortality weekly report.

[7]  T. R. Peters,et al.  Evaluation of the limit of detection of the BD Veritor™ system flu A+B test and two rapid influenza detection tests for influenza virus. , 2013, Diagnostic microbiology and infectious disease.

[8]  W. Kim,et al.  Evaluation of Sofia fluorescent immunoassay analyzer for influenza A/B virus. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  R. Garten,et al.  Analytical detection of influenza A(H3N2)v and other A variant viruses from the USA by rapid influenza diagnostic tests , 2012, Influenza and other respiratory viruses.

[10]  Madhukar Pai,et al.  Accuracy of Rapid Influenza Diagnostic Tests , 2012, Annals of Internal Medicine.

[11]  C. Ginocchio,et al.  Current Best Practices for Respiratory Virus Testing , 2011, Journal of Clinical Microbiology.

[12]  S. Cole,et al.  Performance of rapid influenza H1N1 diagnostic tests: a meta‐analysis , 2011, Influenza and other respiratory viruses.

[13]  Y. Hsieh,et al.  A meta-analysis of point-of-care laboratory tests in the diagnosis of novel 2009 swine-lineage pandemic influenza A (H1N1). , 2011, Diagnostic microbiology and infectious disease.

[14]  M. Landry.  Diagnostic tests for influenza infection , 2011, Current opinion in pediatrics.

[15]  Y. Kawaoka,et al.  Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 Viruses , 2010, Journal of Clinical Microbiology.

[16]  R. Jarman,et al.  The impact of primer and probe-template mismatches on the sensitivity of pandemic influenza A/H1N1/2009 virus detection by real-time RT-PCR. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  Carlos G. Grijalva,et al.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.

[18]  J. M. Crawford,et al.  Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak , 2009, Journal of Clinical Virology.

[19]  Ramakrishna Prasad,et al.  Low sensitivity of rapid diagnostic test for influenza. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Sung,et al.  Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. , 2008, The Journal of pediatrics.

[22]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[24]  B. Bonsu,et al.  Evaluation of the Quidel QuickVue Test for Detection of Influenza A and B Viruses in the Pediatric Emergency Medicine Setting by Use of Three Specimen Collection Methods , 2006, Journal of Clinical Microbiology.

[25]  L. Brammer,et al.  Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012. , 2012, MMWR. Morbidity and mortality weekly report.

[26]  M. Shaw,et al.  Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. , 2009, MMWR. Morbidity and mortality weekly report.